B cell epitopes of the major timothy grass pollen allergen, Phl p 1, revealed by gene fragmentation as candidates for immunotherapy

Tanja Ball, Thomas Fuchs, Wolfgang R. Sperr, Peter Valent, Luca Vangelista, Dietrich Kraft, Rudolf Valenta

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Group 1 grass pollen allergens are recognized by IgE antibodies of almost 40% of allergic individuals and therefore belong to the most important elicitors of Type I allergy worldwide. We have previously isolated the cDNA coding for the group 1 allergen from timothy grass, Phl p 1, and demonstrated that recombinant Phl p 1 contains most of the B cell as well as T cell epitopes of group 1 allergens from a variety of grass and corn species. Here we determine continuous B cell epitopes of Phl p 1 by gene fragmentation. IgE antibodies of grass pollen allergic patients identified five continuous epitope-containing areas that on an average bound 40% of Phl p 1-specific IgE antibodies and were stably recognized in the course of disease. In contrast to untreated patients, patients undergoing grass pollen immunotherapy started to mount IgG4 antibodies to the recombinant IgE-defined fragments in the course of immunotherapy. The protective role of these IgG4 antibodies is demonstrated by observations that 1) increases in rPhl p 1 fragment-specific IgG4 were in parallel with decreases in Phl p 1-specific IgE, and 2) preincubation of rPhl p 1 with patients sera containing rPhl p 1 fragment- specific IgG4 blocked histamine release from basophils of an untreated grass pollen allergic patient. We propose to use recombinant Phl p 1 fragments for active immunotherapy in order to induce protective IgG responses against IgE epitopes in grass pollen allergic patients. This concept may be applied for the development of allergy vaccines whenever the primary sequence or structure of an allergen is available.

Original languageEnglish
Pages (from-to)1277-1290
Number of pages14
JournalFASEB Journal
Volume13
Issue number11
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Phleum
B-Lymphocyte Epitopes
Phleum pratense
immunotherapy
Pollen
allergens
Poaceae
Immunotherapy
Allergens
Immunoglobulin E
epitopes
B-lymphocytes
Genes
pollen
grasses
Immunoglobulin G
antibodies
Antibodies
Allergies
genes

Keywords

  • Allergen gene fragmentation
  • Blocking antibodies
  • Immunotherapy
  • Type I allergy

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

B cell epitopes of the major timothy grass pollen allergen, Phl p 1, revealed by gene fragmentation as candidates for immunotherapy. / Ball, Tanja; Fuchs, Thomas; Sperr, Wolfgang R.; Valent, Peter; Vangelista, Luca; Kraft, Dietrich; Valenta, Rudolf.

In: FASEB Journal, Vol. 13, No. 11, 1999, p. 1277-1290.

Research output: Contribution to journalArticle

Ball, T, Fuchs, T, Sperr, WR, Valent, P, Vangelista, L, Kraft, D & Valenta, R 1999, 'B cell epitopes of the major timothy grass pollen allergen, Phl p 1, revealed by gene fragmentation as candidates for immunotherapy', FASEB Journal, vol. 13, no. 11, pp. 1277-1290.
Ball, Tanja ; Fuchs, Thomas ; Sperr, Wolfgang R. ; Valent, Peter ; Vangelista, Luca ; Kraft, Dietrich ; Valenta, Rudolf. / B cell epitopes of the major timothy grass pollen allergen, Phl p 1, revealed by gene fragmentation as candidates for immunotherapy. In: FASEB Journal. 1999 ; Vol. 13, No. 11. pp. 1277-1290.
@article{59a399ae3d9f4a26ad310193d570b1fb,
title = "B cell epitopes of the major timothy grass pollen allergen, Phl p 1, revealed by gene fragmentation as candidates for immunotherapy",
abstract = "Group 1 grass pollen allergens are recognized by IgE antibodies of almost 40{\%} of allergic individuals and therefore belong to the most important elicitors of Type I allergy worldwide. We have previously isolated the cDNA coding for the group 1 allergen from timothy grass, Phl p 1, and demonstrated that recombinant Phl p 1 contains most of the B cell as well as T cell epitopes of group 1 allergens from a variety of grass and corn species. Here we determine continuous B cell epitopes of Phl p 1 by gene fragmentation. IgE antibodies of grass pollen allergic patients identified five continuous epitope-containing areas that on an average bound 40{\%} of Phl p 1-specific IgE antibodies and were stably recognized in the course of disease. In contrast to untreated patients, patients undergoing grass pollen immunotherapy started to mount IgG4 antibodies to the recombinant IgE-defined fragments in the course of immunotherapy. The protective role of these IgG4 antibodies is demonstrated by observations that 1) increases in rPhl p 1 fragment-specific IgG4 were in parallel with decreases in Phl p 1-specific IgE, and 2) preincubation of rPhl p 1 with patients sera containing rPhl p 1 fragment- specific IgG4 blocked histamine release from basophils of an untreated grass pollen allergic patient. We propose to use recombinant Phl p 1 fragments for active immunotherapy in order to induce protective IgG responses against IgE epitopes in grass pollen allergic patients. This concept may be applied for the development of allergy vaccines whenever the primary sequence or structure of an allergen is available.",
keywords = "Allergen gene fragmentation, Blocking antibodies, Immunotherapy, Type I allergy",
author = "Tanja Ball and Thomas Fuchs and Sperr, {Wolfgang R.} and Peter Valent and Luca Vangelista and Dietrich Kraft and Rudolf Valenta",
year = "1999",
language = "English",
volume = "13",
pages = "1277--1290",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "11",

}

TY - JOUR

T1 - B cell epitopes of the major timothy grass pollen allergen, Phl p 1, revealed by gene fragmentation as candidates for immunotherapy

AU - Ball, Tanja

AU - Fuchs, Thomas

AU - Sperr, Wolfgang R.

AU - Valent, Peter

AU - Vangelista, Luca

AU - Kraft, Dietrich

AU - Valenta, Rudolf

PY - 1999

Y1 - 1999

N2 - Group 1 grass pollen allergens are recognized by IgE antibodies of almost 40% of allergic individuals and therefore belong to the most important elicitors of Type I allergy worldwide. We have previously isolated the cDNA coding for the group 1 allergen from timothy grass, Phl p 1, and demonstrated that recombinant Phl p 1 contains most of the B cell as well as T cell epitopes of group 1 allergens from a variety of grass and corn species. Here we determine continuous B cell epitopes of Phl p 1 by gene fragmentation. IgE antibodies of grass pollen allergic patients identified five continuous epitope-containing areas that on an average bound 40% of Phl p 1-specific IgE antibodies and were stably recognized in the course of disease. In contrast to untreated patients, patients undergoing grass pollen immunotherapy started to mount IgG4 antibodies to the recombinant IgE-defined fragments in the course of immunotherapy. The protective role of these IgG4 antibodies is demonstrated by observations that 1) increases in rPhl p 1 fragment-specific IgG4 were in parallel with decreases in Phl p 1-specific IgE, and 2) preincubation of rPhl p 1 with patients sera containing rPhl p 1 fragment- specific IgG4 blocked histamine release from basophils of an untreated grass pollen allergic patient. We propose to use recombinant Phl p 1 fragments for active immunotherapy in order to induce protective IgG responses against IgE epitopes in grass pollen allergic patients. This concept may be applied for the development of allergy vaccines whenever the primary sequence or structure of an allergen is available.

AB - Group 1 grass pollen allergens are recognized by IgE antibodies of almost 40% of allergic individuals and therefore belong to the most important elicitors of Type I allergy worldwide. We have previously isolated the cDNA coding for the group 1 allergen from timothy grass, Phl p 1, and demonstrated that recombinant Phl p 1 contains most of the B cell as well as T cell epitopes of group 1 allergens from a variety of grass and corn species. Here we determine continuous B cell epitopes of Phl p 1 by gene fragmentation. IgE antibodies of grass pollen allergic patients identified five continuous epitope-containing areas that on an average bound 40% of Phl p 1-specific IgE antibodies and were stably recognized in the course of disease. In contrast to untreated patients, patients undergoing grass pollen immunotherapy started to mount IgG4 antibodies to the recombinant IgE-defined fragments in the course of immunotherapy. The protective role of these IgG4 antibodies is demonstrated by observations that 1) increases in rPhl p 1 fragment-specific IgG4 were in parallel with decreases in Phl p 1-specific IgE, and 2) preincubation of rPhl p 1 with patients sera containing rPhl p 1 fragment- specific IgG4 blocked histamine release from basophils of an untreated grass pollen allergic patient. We propose to use recombinant Phl p 1 fragments for active immunotherapy in order to induce protective IgG responses against IgE epitopes in grass pollen allergic patients. This concept may be applied for the development of allergy vaccines whenever the primary sequence or structure of an allergen is available.

KW - Allergen gene fragmentation

KW - Blocking antibodies

KW - Immunotherapy

KW - Type I allergy

UR - http://www.scopus.com/inward/record.url?scp=0032783475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032783475&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 1277

EP - 1290

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 11

ER -